Licensing

LICENSING OF GRASSP

The GRASSP is currently being used worldwide in 9 countries and in multiple SCI centres.

Since 2009 the GRASSP has been available to the SCI community for use.

The GRASSP Inventors group has created a tiered licensing process that is managed by the UHN Technology Transfer and Business Office.

The licensing system is designed to ensure there is a fair opportunity for all parties choosing to use GRASSP in their work. The licensing process is a separate process from the purchase of GRASSP kits. Please read the tiers below to understand within which category your research falls into. If you have queries, you may contact Dr. Sukhvinder Kalsi-Ryan directly at Sukhvinder.kalsi-ryan@uhn.ca.

 

Licensing Tiers:

 

Tier 1

Clinical License for the individual purchasing of the product. This agreement is executed online when the GRASSP is purchased. There is no fee for this license, only that the purchaser is aware that the use of the GRASSP Kit they are purchasing is meant for clinical implementation. The purchaser will not collect data for a sponsored driven study within this agreement.

Tier 2

Academic License for use within an investigator driven study, that is or is not funded by a not for profit granting foundation/agency. This license can apply to primary investigators, graduate students, academic institutions, research institutes and healthcare institutes. There is no fee for this license, however, a data sharing agreement is required. The UHN Technology Transfer and Business Office will execute the license. The de-identified GRASSP data collected in the study will be requested at the end of the study. The data transfer agreement (DTA) will be executed by the KITE Research Institute-UHN. The specific data elements that will be requested will be included in the DTA.

Tier 3

Industry License for a company of for-profit organization conducting a study or trial. This license requires a fee that is executed with the UHN Technology Transfer and Business Office.

Tier 4

Private Healthcare Institutes using GRASSP as a part of the medical record or charging a third party to provide GRASSP results. This license requires a fee that is executed with the UHN Technology Transfer and Business Office.

For Tier 2 through to Tier 4 licenses, please reach out directly to UHN:

Laura Farran

Senior Business Development and Commercialization Officer
Commercialize at UHN
101 College Street, Suite 150
Toronto, ON M5G 1L7
Fax: 416-977-4765
Email: laura.farran@uhn.ca

    CLINICAL LICENSE AGREEMENT: PLEASE READ THE FOLLOWING UP TO DATE LICENSE AGREEMENT ("AGREEMENT") CAREFULLY BEFORE CONTINUING. WITH YOUR ACCEPTANCE, THIS IS A LEGAL CONTRACT BETWEEN NEURAL OUTCOMES CONSULTING, INC. ("NOCI")/UNIVERSITY HEALTH NETWORK (UHN) AND YOU ("YOU"). BY CLICKING ON THE "ACCEPT" BUTTON, OR BY DOWNLOADING, ACCESSING OR USING THE CONTENT, YOU ACCEPT ALL OF THE TERMS AND CONDITIONS OF THIS AGREEMENT AND AGREE TO BE BOUND BY THIS AGREEMENT. IF YOU DO NOT ACCEPT THE TERMS OF THIS AGREEMENT, YOU ARE NOT PERMITTED TO USE THE CONTENT. IN SUCH CASE, CLICK THE "I do not agree to the terms of the CLINICAL LICENSE AGREEMENT" BUTTON. The license granted in this AGREEMENT is only for the personal use of individual healthcare providers or consumers. License agreements for all other professionals and organizations must be arranged through UHN. Please contact Dr.Kalsi-Ryan skr@neuraloutcomes.com for further inquiries about licensing.
Your Cart is empty.

If there are any difficulties with the website, please contact us directly at

timryan@neuraloutcomes.com or skr@neuraloutcomes.com.